Immunome Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 7.59 M | $163.14 M | 30.44% | 8.63% |
| VANGUARD GROUP INC | 01/29/2026 | 6.04 M | $129.71 M | 23.39% | 6.87% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/11/2026 | 4.69 M | $100.64 M | 55.25% | 5.33% |
| STATE STREET CORP | 02/13/2026 | 3.87 M | $83.08 M | 37.95% | 4.40% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 3.71 M | $79.60 M | 432.05% | 4.21% |
| JPMORGAN CHASE & CO | 02/11/2026 | 2.86 M | $61.34 M | 8,659.15% | 3.25% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 2.86 M | $61.34 M | -30.00% | 3.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.36 M | $50.73 M | 24.64% | 2.68% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 2.00 M | $42.96 M | -4.76% | 2.27% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.74 M | $37.39 M | 106.95% | 1.98% |
| MORGAN STANLEY | 02/13/2026 | 1.71 M | $36.71 M | -6.80% | 1.94% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 1.62 M | $34.76 M | 271.17% | 1.84% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.58 M | $33.84 M | 23.59% | 1.79% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 1.40 M | $30.17 M | 27.11% | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 1.13 M | $24.19 M | 100.00% | 1.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 934.46 K | $20.07 M | 267.80% | 1.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 840.69 K | $18.06 M | 26.68% | 0.96% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 832.08 K | $17.87 M | 9.03% | 0.95% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 793.36 K | $17.04 M | -25.07% | 0.90% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 779.58 K | $16.75 M | 100.00% | 0.89% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 759.19 K | $16.31 M | 8.26% | 0.86% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 752.73 K | $16.17 M | 260.25% | 0.86% |
| MARSHALL WACE, LLP | 02/13/2026 | 737.12 K | $15.83 M | 6.49% | 0.84% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2026 | 732.51 K | $15.73 M | 45.77% | 0.83% |
| NAN FUNG TRINITY (HK) LTD | 02/04/2026 | 714.55 K | $15.35 M | 20.68% | 0.81% |
| CANDRIAM S.C.A. | 02/13/2026 | 539.88 K | $11.60 M | -37.19% | 0.61% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 435.12 K | $9.35 M | 2.09% | 0.49% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 432.70 K | $9.29 M | 120.99% | 0.49% |
| ATIKA CAPITAL MANAGEMENT LLC | 02/13/2026 | 334.34 K | $7.18 M | 100.00% | 0.38% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 316.38 K | $6.80 M | -6.49% | 0.36% |
| UBS GROUP AG | 01/29/2026 | 307.19 K | $6.60 M | -47.39% | 0.35% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 293.75 K | $6.31 M | 100.00% | 0.33% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 286.36 K | $6.15 M | 11.24% | 0.33% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 277.81 K | $5.97 M | -20.88% | 0.32% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 02/12/2026 | 274.86 K | $5.90 M | 100.00% | 0.31% |
| INVESCO LTD. | 02/19/2026 | 270.07 K | $5.80 M | 382.12% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 263.37 K | $5.66 M | 21.35% | 0.30% |
| BARCLAYS PLC | 02/13/2026 | 246.07 K | $5.29 M | 18.01% | 0.28% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 237.27 K | $5.03 M | -18.31% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 220.90 K | $4.74 M | 299.46% | 0.25% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 202.72 K | $4.35 M | 119.97% | 0.23% |
| NEO IVY CAPITAL MANAGEMENT | 02/13/2026 | 192.64 K | $4.14 M | 100.00% | 0.22% |
| JANE STREET GROUP, LLC | 02/12/2026 | 191.50 K | $4.11 M | 100.00% | 0.22% |
| SWISS NATIONAL BANK | 02/12/2026 | 185.00 K | $3.97 M | 37.04% | 0.21% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 182.38 K | $3.92 M | 28,530.93% | 0.21% |
| ATOM INVESTORS LP | 02/17/2026 | 175.77 K | $3.78 M | 100.00% | 0.20% |
| GILDER GAGNON HOWE & CO LLC | 02/17/2026 | 174.86 K | $3.76 M | 31.36% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 170.91 K | $3.67 M | 143.59% | 0.19% |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 01/28/2026 | 170.00 K | $3.65 M | 100.00% | 0.19% |
| NUVEEN, LLC | 02/12/2026 | 169.35 K | $3.64 M | 16.51% | 0.19% |
Immunome Inc institutional Ownership - FAQ's
During the previous two years, 162 institutional investors and hedge funds held shares of Immunome Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 7.59 M
VANGUARD GROUP INC: 6.04 M
PRIMECAP MANAGEMENT CO/CA/: 4.69 M
STATE STREET CORP: 3.87 M
JPMORGAN CHASE & CO: 2.86 M
EcoR1 Capital, LLC: 2.86 M
49.36% of Immunome Inc stock is owned by institutional investors.
Institutional investors have bought a total of 56.51 M shares in the last 24 months. This purchase volume represents approximately $1.24 B in transactions.